Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 493

1.

Cost-effectiveness analysis of papillary thyroid cancer surveillance.

Wang LY, Roman BR, Migliacci JC, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Cancer. 2015 Aug 17. doi: 10.1002/cncr.29633. [Epub ahead of print]

PMID:
26280253
2.

Torsional Fracture of the Humerus after Subpectoral Biceps Tenodesis with an Interference Screw: A Biomechanical Cadaveric Study.

Beason DP, Shah JP, Duckett JW, Jost PW, Fleisig GS, Cain EL Jr.

Clin Biomech (Bristol, Avon). 2015 Jul 26. pii: S0268-0033(15)00206-5. doi: 10.1016/j.clinbiomech.2015.07.009. [Epub ahead of print]

PMID:
26255072
3.

Three dimensional dose distribution comparison of simple and complex acquisition trajectories in dedicated breast CT.

Shah JP, Mann SD, McKinley RL, Tornai MP.

Med Phys. 2015 Aug;42(8):4497. doi: 10.1118/1.4923169.

PMID:
26233179
4.

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP.

Ann Surg Oncol. 2015 Jul 28. [Epub ahead of print]

PMID:
26215199
5.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-56.

PMID:
26150579
6.

Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell MJ, Shen WT, Vaisman F, Momesso D, Corbo R, Vaisman M, Shaha A, Tuttle RM, Shah JP, Patel SG.

Thyroid. 2015 Aug 12. [Epub ahead of print]

PMID:
26148759
7.

Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.

Wang LY, Ghossein R, Palmer FL, Nixon IJ, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Thyroid. 2015 Jul 30. [Epub ahead of print]

PMID:
26122000
8.

Role of RAI in the management of incidental N1a disease in papillary thyroid cancer.

Wang LY, Palmer FL, Migliacci JC, Nixon IJ, Shaha AR, Shah JP, Tuttle RM, Patel SG, Ganly I.

Clin Endocrinol (Oxf). 2015 Jun 3. doi: 10.1111/cen.12828. [Epub ahead of print]

PMID:
26041503
9.

Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?

Ibrahimpasic T, Ghossein R, Carlson DL, Nixon IJ, Palmer FL, Patel SG, Tuttle RM, Shaha A, Shah JP, Ganly I.

Ann Surg Oncol. 2015 Apr 17. [Epub ahead of print]

PMID:
25893415
10.

New and emerging therapeutic options for thyroid carcinoma.

Shah JP, Clayman GL, Wirth LJ.

Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-17, 1; quiz 2 p following 18.

PMID:
25856096
11.

Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.

Iyer NG, Dogan S, Palmer F, Rahmati R, Nixon IJ, Lee N, Patel SG, Shah JP, Ganly I.

Ann Surg Oncol. 2015 Mar 24. [Epub ahead of print]

PMID:
25801358
12.

Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.

Fury MG, Xiao H, Sherman EJ, Baxi S, Smith-Marrone S, Schupak K, Gewanter R, Gelblum D, Haque S, Schoder H, Shah JP, Katabi N, Kurtzman R, Lipson B, Cox L, Lee NY, Pfister DG.

Head Neck. 2015 Mar 17. doi: 10.1002/hed.24041. [Epub ahead of print]

PMID:
25784616
13.

New frontiers and treatment paradigms for thyroid carcinoma.

Haddad R, Sherman SI, Shah JP, Wirth LJ.

Clin Adv Hematol Oncol. 2014 Jul;12(7 Suppl 14):3-21; quiz 22. No abstract available.

PMID:
25768715
14.

Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.

Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 May;25(5):503-8. doi: 10.1089/thy.2015.0052. Epub 2015 Mar 31.

PMID:
25748079
15.

Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Ali S, Bryant R, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I.

Ann Surg Oncol. 2015 Mar 6. [Epub ahead of print]

PMID:
25743328
16.

Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective.

Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L.

PM R. 2015 Jul;7(7):746-61. doi: 10.1016/j.pmrj.2015.01.024. Epub 2015 Feb 24. Review.

PMID:
25724849
17.

Soft tissue sarcoma of the head & neck: nomogram validation and analysis of staging systems.

Shuman AG, Brennan MF, Palmer FL, Kuk D, Moraco N, Singer S, Shah JP, Patel SG.

J Surg Oncol. 2015 May;111(6):690-5. doi: 10.1002/jso.23868. Epub 2015 Feb 24.

PMID:
25711850
18.

Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.

Wang LY, Palmer FL, Nixon IJ, Tuttle RM, Shah JP, Patel SG, Shaha AR, Ganly I.

Ann Surg Oncol. 2015 Feb 10. [Epub ahead of print]

PMID:
25665952
19.

Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer.

Roman BR, Patel SG, Wang MB, Pou AM, Holsinger FC, Myssiorek D, Goldenberg D, Swisher-McClure S, Lin A, Shah JP, Shea JA.

J Natl Compr Canc Netw. 2015 Jan;13(1):69-77.

PMID:
25583771
20.

Brønsted acid catalyzed monoalkylation of anilines with trichloroacetimidates.

Wallach DR, Stege PC, Shah JP, Chisholm JD.

J Org Chem. 2015 Feb 6;80(3):1993-2000. doi: 10.1021/jo5027222. Epub 2015 Jan 16.

PMID:
25568933
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk